These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 26153725)

  • 1. Amyloid-β as a biomarker for Alzheimer's disease: quantification methods in body fluids.
    Galozzi S; Marcus K; Barkovits K
    Expert Rev Proteomics; 2015 Aug; 12(4):343-54. PubMed ID: 26153725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High performance plasma amyloid-β biomarkers for Alzheimer's disease.
    Nakamura A; Kaneko N; Villemagne VL; Kato T; Doecke J; Doré V; Fowler C; Li QX; Martins R; Rowe C; Tomita T; Matsuzaki K; Ishii K; Ishii K; Arahata Y; Iwamoto S; Ito K; Tanaka K; Masters CL; Yanagisawa K
    Nature; 2018 Feb; 554(7691):249-254. PubMed ID: 29420472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of amyloid beta peptides in body fluids for the diagnosis of alzheimer's disease: Where do we stand?
    Veerabhadrappa B; Delaby C; Hirtz C; Vialaret J; Alcolea D; Lleó A; Fortea J; Santosh MS; Choubey S; Lehmann S
    Crit Rev Clin Lab Sci; 2020 Mar; 57(2):99-113. PubMed ID: 31661652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mirror Image of the Amyloid-β Species in Cerebrospinal Fluid and Cerebral Amyloid in Alzheimer's Disease.
    Catania M; Di Fede G; Tonoli E; Benussi L; Pasquali C; Giaccone G; Maderna E; Ghidoni R; Tagliavini F
    J Alzheimers Dis; 2015; 47(4):877-81. PubMed ID: 26401767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.
    Asih PR; Chatterjee P; Verdile G; Gupta VB; Trengove RD; Martins RN
    Neurodegener Dis Manag; 2014; 4(5):363-78. PubMed ID: 25405650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biomarkers of Alzheimer disease].
    Rachel W; Grela A; Zyss T; Zieba A; Piekoszewski W
    Przegl Lek; 2014; 71(2):98-101. PubMed ID: 25016785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of Alzheimer's disease: the present and the future.
    Lehmann S; Delaby C; Touchon J; Hirtz C; Gabelle A
    Rev Neurol (Paris); 2013 Oct; 169(10):719-23. PubMed ID: 24021316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
    Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
    Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research progress on humoral biomarkers of Alzheimer's disease: A review.
    Zhang H; Fu X; Yang M; Song X; Li M; Wang X
    Medicine (Baltimore); 2024 Jul; 103(30):e38978. PubMed ID: 39058878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity.
    Hampel H; Mitchell A; Blennow K; Frank RA; Brettschneider S; Weller L; Möller HJ
    J Neural Transm (Vienna); 2004 Mar; 111(3):247-72. PubMed ID: 14991453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid biomarkers for pathological processes in Alzheimer's disease.
    Rosén C; Zetterberg H
    Curr Opin Psychiatry; 2013 May; 26(3):276-82. PubMed ID: 23493130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biomarkers for early diagnosis of Alzheimer's disease].
    Frederiksen KS; Hasselbalch S; Law I; Højgaard L; Waldemar G
    Ugeskr Laeger; 2015 Jun; 177(24):. PubMed ID: 26058526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-β-Secondary Structure Distribution in Cerebrospinal Fluid and Blood Measured by an Immuno-Infrared-Sensor: A Biomarker Candidate for Alzheimer's Disease.
    Nabers A; Ollesch J; Schartner J; Kötting C; Genius J; Hafermann H; Klafki H; Gerwert K; Wiltfang J
    Anal Chem; 2016 Mar; 88(5):2755-62. PubMed ID: 26828829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of Alzheimer's disease in body fluids.
    Zheng Y; He J; Hong T
    Sci China Life Sci; 2010 Apr; 53(4):490-6. PubMed ID: 20596916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry analysis of the diversity of Aβ peptides: difficulties and future perspectives for AD biomarker discovery.
    Zakharova NV; Bugrova AE; Kononikhin AS; Indeykina MI; Popov IA; Nikolaev EN
    Expert Rev Proteomics; 2018 Oct; 15(10):773-775. PubMed ID: 30253669
    [No Abstract]   [Full Text] [Related]  

  • 18. Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.
    Mattsson N; Zegers I; Andreasson U; Bjerke M; Blankenstein MA; Bowser R; Carrillo MC; Gobom J; Heath T; Jenkins R; Jeromin A; Kaplow J; Kidd D; Laterza OF; Lockhart A; Lunn MP; Martone RL; Mills K; Pannee J; Ratcliffe M; Shaw LM; Simon AJ; Soares H; Teunissen CE; Verbeek MM; Umek RM; Vanderstichele H; Zetterberg H; Blennow K; Portelius E
    Biomark Med; 2012 Aug; 6(4):409-17. PubMed ID: 22917143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applications.
    Bros P; Delatour V; Vialaret J; Lalere B; Barthelemy N; Gabelle A; Lehmann S; Hirtz C
    Clin Chem Lab Med; 2015 Sep; 53(10):1483-93. PubMed ID: 25719328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease.
    Lista S; Garaci FG; Ewers M; Teipel S; Zetterberg H; Blennow K; Hampel H
    Alzheimers Dement; 2014 May; 10(3):381-92. PubMed ID: 23850330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.